{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:00:11Z","timestamp":1774000811564,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/lgt.0000000000000012","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T09:59:24Z","timestamp":1398419964000},"page":"338-343","source":"Crossref","is-referenced-by-count":16,"title":["Posttreatment Assessment of Women at Risk of Developing High-Grade Cervical Disease"],"prefix":"10.1097","volume":"18","author":[{"given":"Margot","family":"H. Uijterwaal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari\u00eblle","family":"Kocken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruud L.M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9ne","family":"H.M. Verheijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo J.M.","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 3","key":"R2-12-20210126","first-page":"S378","article-title":"Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"R3-12-20210126","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1470-2045(11)70078-X","article-title":"Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.","volume":"12","author":"Kocken","year":"2011","journal-title":"Lancet Oncol"},{"key":"R4-12-20210126","doi-asserted-by":"crossref","first-page":"e7186","DOI":"10.1136\/bmj.e7186","article-title":"Follow-up after treatment for cervical intraepithelial neoplasia.","volume":"345","author":"Bleeker","year":"2012","journal-title":"BMJ"},{"key":"R7-12-20210126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0b013e318159408b","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"R8-12-20210126","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ijc.23824","article-title":"Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residualrecurrent disease.","volume":"124","author":"Bais","year":"2009","journal-title":"Int J Cancer"},{"key":"R9-12-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-8258(03)00415-3","article-title":"HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.","volume":"91","author":"Zielinski","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R10-12-20210126","doi-asserted-by":"crossref","first-page":"e6855","DOI":"10.1136\/bmj.e6855","article-title":"Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population-based cohort study.","volume":"345","author":"Rebolj","year":"2012","journal-title":"BMJ"},{"key":"R11-12-20210126","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2012.01.015","article-title":"High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis.","volume":"125","author":"Kocken","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"suppl 5","key":"R12-12-20210126","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"R13-12-20210126","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening. Second editionsummary document.","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann Oncol"},{"key":"R17-12-20210126","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Cancer"},{"key":"R18-12-20210126","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1054\/bjoc.2000.1689","article-title":"Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia.","volume":"84","author":"Nobbenhuis","year":"2001","journal-title":"Br J Cancer"},{"key":"R19-12-20210126","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ajog.2008.11.031","article-title":"Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review.","volume":"200","author":"Chan","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R20-12-20210126","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening.","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"R21-12-20210126","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ijc.25745","article-title":"Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.","volume":"129","author":"Heymans","year":"2011","journal-title":"Int J Cancer"},{"key":"R22-12-20210126","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1471-0528.2008.01748.x","article-title":"HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia.","volume":"115","author":"Kitchener","year":"2008","journal-title":"BJOG"},{"key":"R23-12-20210126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ctrv.2003.07.008","article-title":"The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature.","volume":"30","author":"Paraskevaidis","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"R24-12-20210126","first-page":"1849","article-title":"Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence Eur J C","volume":"43","author":"Strander","year":"2007","journal-title":"ancer"},{"key":"R25-12-20210126","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00006254-200407000-00024","article-title":"HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis.","volume":"59","author":"Zielinski","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"R26-12-20210126","first-page":"199","article-title":"Management of cervical neoplasia: a 13-year experience with cryotherapy and laser.","volume":"5","author":"Persad","year":"2001","journal-title":"J Low Genit Tract Dis"},{"key":"R27-12-20210126","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jnci\/djp089","article-title":"Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study.","volume":"101","author":"Melnikow","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R28-12-20210126","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","article-title":"Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study.","volume":"331","author":"Kalliala","year":"2005","journal-title":"BMJ"},{"key":"R29-12-20210126","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(96)08295-5","article-title":"Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.","volume":"349","author":"Soutter","year":"1997","journal-title":"Lancet"},{"key":"R30-12-20210126","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/ijc.21604","article-title":"Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia.","volume":"118","author":"Soutter","year":"2006","journal-title":"Int J Cancer"},{"key":"R33-12-20210126","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/1055-9965.EPI-05-0845","article-title":"Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.","volume":"15","author":"Kreimer","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R34-12-20210126","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1525-1438.2007.00965.x","article-title":"Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions.","volume":"18","author":"Prato","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R35-12-20210126","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2006.04.016","article-title":"Pre- and post-conization high-risk HPV testing predicts residualrecurrent disease in patients treated for CIN 2-3.","volume":"103","author":"Alonso","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R36-12-20210126","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1471-0528.2010.02806.x","article-title":"Dynamic spectral imaging colposcopy: higher sensitivity for detection of premalignant cervical lesions.","volume":"118","author":"Louwers","year":"2011","journal-title":"BJOG"},{"key":"R37-12-20210126","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","article-title":"Number of cervical biopsies and sensitivity of colposcopy.","volume":"108","author":"Gage","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R38-12-20210126","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/LGT.0b013e3181e9635b","article-title":"Random biopsy after colposcopy-directed biopsy improves the diagnosis of cervical intraepithelial neoplasia grade 2 or worse.","volume":"14","author":"Nam","year":"2010","journal-title":"J Low Genit Tract Dis"},{"key":"R40-12-20210126","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/clinids\/18.3.428","article-title":"Quality standard for the treatment of bacteremia. Infectious Diseases Society of America.","volume":"18","author":"Gross","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R41-12-20210126","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-0528.2007.01265.x","article-title":"Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia.","volume":"114","author":"Coupe","year":"2007","journal-title":"BJOG"},{"key":"R42-12-20210126","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ygyno.2011.11.039","article-title":"Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases.","volume":"124","author":"Costa","year":"2012","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Lower Genital Tract Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LGT.0000000000000012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:49:37Z","timestamp":1620956977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00128360-201410000-00012"}},"subtitle":["Proposal for New Guidelines Based on Data From The Netherlands"],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/lgt.0000000000000012","relation":{},"ISSN":["1089-2591"],"issn-type":[{"value":"1089-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}